✦ LIBER ✦

386: Impact of iloprost and bosentan therapy on the outcome of patients with end-stage primary pulmonary hypertension

✍ Scribed by M. Dandel; H.B. Lehmkuhl; Y. Weng; S. Mulahasanovic; O. Grauhan; C. Knosalla; R. Hetzer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of patients with primary pulmona

✍ M. Dandel; H.B. Lehmkuhl; Y. Weng; S. Mulahasanovic; H. Böttcher; C. Knosalla; O 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Survival of Patients With Idiopathic Pul

✍ Michael Dandel; Hans B. Lehmkuhl; Sead Mulahasanovic; Yuguo Weng; Dagmar Kemper; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Effect of Pulmonary Hypertension in Pati

✍ M.K. Omari; S.A. Smith; G. Jacobsen; V. Kaza 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Long-term outcome and effects of oral bo

✍ Hsao-Hsun Hsu; Jin-Shing Chen; Robert J. Chen; Wen-Je Ko; Shuenn-Wen Kuo; En-Tin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 221 KB

823 Impact of Pulmonary Venous Hypertens

✍ K.H. Andersen; M. Iversen; J. Kjaergaard; J. Mortensen; J.-E. Nielsen-Kudsk; E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Long term outcome of bosentan treatment

✍ R.E Girgis; S.C Mathai; J.A Krishnan; F.M Wigley; P.M Hassoun 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 68 KB